Approved consistent with the understanding that any changes made as a result of the pretest will need to be submitted for approval prior to fielding the main study.
Inventory as of this Action
Requested
Previously Approved
08/31/2023
36 Months From Approved
4,423
0
0
499
0
0
0
0
0
This ICR is a web-based survey to investigate healthcare providersâ (HCPsâ) awareness, perceptions, and beliefs about the benefits and risks of an FDA-approved product that includes a boxed warning as part of its approved prescribing information. This study will strengthen FDAâs understanding of how HCPs may receive, process, and use boxed warning information and identify HCPsâ potential information needs with respect to the topics addressed by a productâs boxed warning. This research will evaluate two treatment scenarios involving an FDA-approved medication or class of medications that include boxed warning information.
On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).
The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control number;
If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.